MYC and neoplasm: For example, in liver cancer, the high expression of FBXO32 may promote tumor proliferation by stabilizing the D-type cyclin (CyclinD), and at the same time improve metabolic inhibition by inhibiting c-Myc, suggesting that its dual effects need to be combined with specific microenvironment analysis (6).